Live Breaking News & Updates on Sputnikv Production

Stay updated with breaking news from Sputnikv production. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Serum Institute gets DCGI nod to manufacture Sputnik V COVID-19 vaccine in India


SII plans to seek restricted emergency use permission of the vaccine in India.
The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with certain conditions, official sources said on Friday.
The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility. “The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis at its licensed Hadapsar facility with certain conditions,” an official source said. ....

Committee On Genetic Manipulation , Gamaleya Research Institute Of Epidemiology , Serum Institute , Serum Institute Of India , Department Of Biotechnology , Gamaleya Research Institute , Review Committee , Genetic Manipulation , Lockdown Extension , Single Day Spik E , Covid 19 Vaccine , Health Ministry , Indian Council For Medical Research , Coronavirus Vaccine , Risk Of Deaths , Coronavirus Cases , Covid Test , Coronavirus Tests , Testing Facilities , Covid Treatment , Personal Protective Equipment , Coronavirus Detection , Covid 19 , Sars Cov 2 Virus , Sars Cov 2 , Coronavirus Lockdown ,